LMO4 demonstrates variable expression in different cancers but its role remains unclear since in breast cancer, high LMO4 expression is associated with a poor prognosis [68], [69], while in pancreatic cancer it is associated with a better survival [70], [71]. This evidence concerns the gene LMO4 and cancer.